June 18, 2013
by MoreRecycling
0 comments

New resistance mechanism to chemotherapy in breast and ovarian cancer

A new study explains why tumors with BRCA1 and BRCA2 mutations stop responding to PARP inhibitor drugs. Continue reading

Share on Facebook

June 17, 2013
by MoreRecycling
0 comments

Medical assessment in the blink of an eye

Have you ever thought that you knew something about the world in the blink of an eye? It turns out that radiologists can do this with mammograms, the x-ray images used for breast cancer screening. Cytologists, who screen micrographic images of cervical… Continue reading

Share on Facebook

June 15, 2013
by MoreRecycling
0 comments

Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors, study suggests

A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a new study. Continue reading

Share on Facebook

June 13, 2013
by MoreRecycling
0 comments

Protein protects against breast cancer recurrence in animal model

Precisely what causes breast cancer recurrence has been poorly understood. But now a piece of the puzzle has fallen into place: Researchers have identified a key molecular player in recurrent breast cancer – a finding that suggests potential new therapeutic strategies. Continue reading

Share on Facebook

June 13, 2013
by MoreRecycling
0 comments

Gene variants may predict who will benefit from breast cancer prevention drugs

In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers have identified two gene variants that may predict which women are most likely to benefit from this therapy. Continue reading

Share on Facebook

June 12, 2013
by MoreRecycling
0 comments

Chemotherapy: Greater potential benefit in overall survival for eribulin compared with capecitabine

Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, showed increased benefit a… Continue reading

Share on Facebook

June 11, 2013
by MoreRecycling
0 comments

Screening fails to affect breast cancer mortality statistics, UK study finds

New research from the UK analysing breast cancer mortality data spanning almost 40 years concludes that breast cancer screening does not yet show an effect on mortality statistics. The research analyzed mortality trends before and after the introductio… Continue reading

Share on Facebook

June 6, 2013
by MoreRecycling
0 comments

Gene variant may provide novel therapy for several cancer types

A novel gene variant found in human and animal tissue may be a promising treatment for cancer, including breast and brain cancer. Continue reading

Share on Facebook

June 6, 2013
by MoreRecycling
0 comments

Evolutionary history of a cancer-related gene

Scientists have described how a genetic duplication that took place in the vertebrate ancestor some 500 million years ago encouraged the evolution of the ASF1b gene; a gene essential for proper cell division and related to some types of cancer such as … Continue reading

Share on Facebook

June 5, 2013
by MoreRecycling
0 comments

Metastatic breast cancer study shows success in finding new treatment

A new study shows success in pinpointing individualized treatment for women with metastatic breast cancer. Continue reading

Share on Facebook

June 4, 2013
by MoreRecycling
0 comments

Scientists find potential new clues for identifying breast cancer risk

New research provides critical insights into how normal breast precursor cells may be genetically vulnerable to develop into cancer. Scientists discovered that a particular class of normal breast precursor cells have short chromosome ends (known as tel… Continue reading

Share on Facebook

June 1, 2013
by MoreRecycling
0 comments

New technology makes breast cancer surgery more precise

Any breast cancer surgeon who regularly performs lumpectomies confronts the question “Did I get it all?” 30 to 60 percent of the time in the US, the answer is “no,” requiring the patient to undergo a second surgery to remove the remaining tumor. Continue reading

Share on Facebook

May 24, 2013
by MoreRecycling
0 comments

Scientists make breast cancer advance that turns previous thinking on its head

Scientists have made an advance in breast cancer research which shows how some enzymes released by cancerous cells could have a protective function. Continue reading

Share on Facebook

May 23, 2013
by MoreRecycling
0 comments

Research identifies a way to make cancer cells more responsive to chemotherapy

Breast cancer characterized as “triple negative” carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn’t kill the cancer cells the way it’s supposed to. New research explains why some cancer cells don’t respond to … Continue reading

Share on Facebook

May 23, 2013
by MoreRecycling
0 comments

Technique to detect breast cancer in urine developed

Medical researchers have developed a new screening method that uses urinalysis to diagnose breast cancer – and determine its severity – before it could be detected with a mammogram. Continue reading

Share on Facebook

May 21, 2013
by MoreRecycling
0 comments

Changing cancer’s environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, scientists have identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse models of prostate, b… Continue reading

Share on Facebook

May 15, 2013
by MoreRecycling
0 comments

Despite new recommendations, women in 40s continue to get routine mammograms at same rate

Women in their 40s continue to undergo routine breast cancer screenings despite national guidelines recommending otherwise, according to new research. Continue reading

Share on Facebook

May 9, 2013
by MoreRecycling
0 comments

Popular diabetes drug does not improve survival rates after cancer

Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study has found the drug may not actually improve survival rates after breast cancer in certain patients. Continue reading

Share on Facebook

May 9, 2013
by MoreRecycling
0 comments

Your immune system: On surveillance in the war against cancer

New research looks at gene expression profiling in breast cancer. Continue reading

Share on Facebook

May 9, 2013
by MoreRecycling
0 comments

Fun and friends help ease the pain of breast cancer

Breast cancer patients who say they have people with whom they have a good time, or have “positive social interactions” with, are better able to deal with pain and other physical symptoms, according to a new study. Continue reading

Share on Facebook